chr8:141462444-141491331 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141454376-141475572 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141466175-141490647 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141454338-141475848 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141454613-141476525 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141569116-141658855 |
chr8:141574194 |
rs2944755 |
EIF2C2 |
Thiazide-induced adverse metabolic effects in hypertensive patients |
intron |
8e-06 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141574277 |
rs2977491 |
EIF2C2 |
Urinary metabolites |
intron |
8.2e-07 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141587404 |
rs9694342 |
EIF2C2 |
Multiple complex diseases |
intron |
0.000397 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141594881 |
rs7009635 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
2.54e-05 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141621038 |
rs7001653 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
0.000239 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141622537 |
rs2176397 |
EIF2C2 |
Cognitive test performance |
intron |
8e-05 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141656155 |
rs11166986 |
NA |
Multiple complex diseases |
NA |
0.000394 |
GWASdb |
| chr8:141569116-141658855 |
chr8:141622215 |
rs13263959 |
LOC105375791 - MIR1302-7 |
Hair color |
intergenic_variant |
8e-07 |
GWAS_Catalog |
| chr8:141569116-141658855 |
chr8:141609134 |
rs1106761 |
LOC105375791 - MIR1302-7 |
Educational attainment (years of education) |
intergenic_variant |
1e-11 |
GWAS_Catalog |
| chr8:141570464-141648834 |
chr8:141574194 |
rs2944755 |
EIF2C2 |
Thiazide-induced adverse metabolic effects in hypertensive patients |
intron |
8e-06 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141574277 |
rs2977491 |
EIF2C2 |
Urinary metabolites |
intron |
8.2e-07 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141587404 |
rs9694342 |
EIF2C2 |
Multiple complex diseases |
intron |
0.000397 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141594881 |
rs7009635 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
2.54e-05 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141621038 |
rs7001653 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
0.000239 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141622537 |
rs2176397 |
EIF2C2 |
Cognitive test performance |
intron |
8e-05 |
GWASdb |
| chr8:141570464-141648834 |
chr8:141622215 |
rs13263959 |
LOC105375791 - MIR1302-7 |
Hair color |
intergenic_variant |
8e-07 |
GWAS_Catalog |
| chr8:141570464-141648834 |
chr8:141609134 |
rs1106761 |
LOC105375791 - MIR1302-7 |
Educational attainment (years of education) |
intergenic_variant |
1e-11 |
GWAS_Catalog |
| chr8:141465990-141480367 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141399304-141476572 |
chr8:141410497 |
rs11778051 |
TRAPPC9 |
Alzheimer's disease |
intron |
0.000705 |
GWASdb |
| chr8:141399304-141476572 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141467235-141482713 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141454925-141476304 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141447443-141477813 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141447063-141476656 |
chr8:141456721 |
rs11777747 |
LOC105375789, MROH5 |
Coronary artery calcification |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr8:141543904-141684045 |
chr8:141574194 |
rs2944755 |
EIF2C2 |
Thiazide-induced adverse metabolic effects in hypertensive patients |
intron |
8e-06 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141574277 |
rs2977491 |
EIF2C2 |
Urinary metabolites |
intron |
8.2e-07 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141587404 |
rs9694342 |
EIF2C2 |
Multiple complex diseases |
intron |
0.000397 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141594881 |
rs7009635 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
2.54e-05 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141621038 |
rs7001653 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
0.000239 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141622537 |
rs2176397 |
EIF2C2 |
Cognitive test performance |
intron |
8e-05 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141656155 |
rs11166986 |
NA |
Multiple complex diseases |
NA |
0.000394 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141663972 |
rs11166990 |
NA |
Brain structure |
NA |
0.000582 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141666413 |
rs11166991 |
NA |
Brain structure |
NA |
0.000662 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141670266 |
rs10088475 |
PTK2 |
Brain structure |
intron |
0.000979 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141675931 |
rs13273096 |
PTK2 |
Brain structure |
intron |
0.00056 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141677324 |
rs7016497 |
PTK2 |
Multiple complex diseases |
intron |
8.39e-05 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141677470 |
rs11166992 |
PTK2 |
Brain structure |
intron |
0.000556 |
GWASdb |
| chr8:141543904-141684045 |
chr8:141622215 |
rs13263959 |
LOC105375791 - MIR1302-7 |
Hair color |
intergenic_variant |
8e-07 |
GWAS_Catalog |
| chr8:141543904-141684045 |
chr8:141546705 |
rs1566080 |
LOC105375791 - MIR1302-7 |
Obesity-related traits |
intergenic_variant |
6e-06 |
GWAS_Catalog |
| chr8:141543904-141684045 |
chr8:141609134 |
rs1106761 |
LOC105375791 - MIR1302-7 |
Educational attainment (years of education) |
intergenic_variant |
1e-11 |
GWAS_Catalog |
| chr8:141514534-141612118 |
chr8:141530057 |
rs10109589 |
NA |
Triglycerides |
NA |
1.06e-05 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141530057 |
rs10109589 |
NA |
Lipid levels |
NA |
2.23e-05 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141534198 |
rs2977451 |
NA |
Fasting plasma glucose |
NA |
2.4e-06 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141538846 |
rs2977453 |
NA |
Primary sclerosing cholangitis |
NA |
0.00014 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141574194 |
rs2944755 |
EIF2C2 |
Thiazide-induced adverse metabolic effects in hypertensive patients |
intron |
8e-06 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141574277 |
rs2977491 |
EIF2C2 |
Urinary metabolites |
intron |
8.2e-07 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141587404 |
rs9694342 |
EIF2C2 |
Multiple complex diseases |
intron |
0.000397 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141594881 |
rs7009635 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
2.54e-05 |
GWASdb |
| chr8:141514534-141612118 |
chr8:141530825 |
rs7837045 |
LOC105375791 - MIR1302-7 |
Breast size |
regulatory_region_variant |
5e-06 |
GWAS_Catalog |
| chr8:141514534-141612118 |
chr8:141546705 |
rs1566080 |
LOC105375791 - MIR1302-7 |
Obesity-related traits |
intergenic_variant |
6e-06 |
GWAS_Catalog |
| chr8:141514534-141612118 |
chr8:141609134 |
rs1106761 |
LOC105375791 - MIR1302-7 |
Educational attainment (years of education) |
intergenic_variant |
1e-11 |
GWAS_Catalog |
| chr8:141517027-141609566 |
chr8:141530057 |
rs10109589 |
NA |
Triglycerides |
NA |
1.06e-05 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141530057 |
rs10109589 |
NA |
Lipid levels |
NA |
2.23e-05 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141534198 |
rs2977451 |
NA |
Fasting plasma glucose |
NA |
2.4e-06 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141538846 |
rs2977453 |
NA |
Primary sclerosing cholangitis |
NA |
0.00014 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141574194 |
rs2944755 |
EIF2C2 |
Thiazide-induced adverse metabolic effects in hypertensive patients |
intron |
8e-06 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141574277 |
rs2977491 |
EIF2C2 |
Urinary metabolites |
intron |
8.2e-07 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141587404 |
rs9694342 |
EIF2C2 |
Multiple complex diseases |
intron |
0.000397 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141594881 |
rs7009635 |
EIF2C2 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
intron |
2.54e-05 |
GWASdb |
| chr8:141517027-141609566 |
chr8:141530825 |
rs7837045 |
LOC105375791 - MIR1302-7 |
Breast size |
regulatory_region_variant |
5e-06 |
GWAS_Catalog |
| chr8:141517027-141609566 |
chr8:141546705 |
rs1566080 |
LOC105375791 - MIR1302-7 |
Obesity-related traits |
intergenic_variant |
6e-06 |
GWAS_Catalog |
| chr8:141517027-141609566 |
chr8:141609134 |
rs1106761 |
LOC105375791 - MIR1302-7 |
Educational attainment (years of education) |
intergenic_variant |
1e-11 |
GWAS_Catalog |
| chr8:141466338-141524371 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141466377-141523727 |
chr8:141480330 |
rs6993904 |
NA |
Response to taxane treatment (placlitaxel) |
NA |
0.000457 |
GWASdb |
| chr8:141515614-141541307 |
chr8:141530057 |
rs10109589 |
NA |
Triglycerides |
NA |
1.06e-05 |
GWASdb |
| chr8:141515614-141541307 |
chr8:141530057 |
rs10109589 |
NA |
Lipid levels |
NA |
2.23e-05 |
GWASdb |
| chr8:141515614-141541307 |
chr8:141534198 |
rs2977451 |
NA |
Fasting plasma glucose |
NA |
2.4e-06 |
GWASdb |
| chr8:141515614-141541307 |
chr8:141538846 |
rs2977453 |
NA |
Primary sclerosing cholangitis |
NA |
0.00014 |
GWASdb |
| chr8:141515614-141541307 |
chr8:141530825 |
rs7837045 |
LOC105375791 - MIR1302-7 |
Breast size |
regulatory_region_variant |
5e-06 |
GWAS_Catalog |
| chr8:141518974-141570542 |
chr8:141530057 |
rs10109589 |
NA |
Triglycerides |
NA |
1.06e-05 |
GWASdb |
| chr8:141518974-141570542 |
chr8:141530057 |
rs10109589 |
NA |
Lipid levels |
NA |
2.23e-05 |
GWASdb |
| chr8:141518974-141570542 |
chr8:141534198 |
rs2977451 |
NA |
Fasting plasma glucose |
NA |
2.4e-06 |
GWASdb |
| chr8:141518974-141570542 |
chr8:141538846 |
rs2977453 |
NA |
Primary sclerosing cholangitis |
NA |
0.00014 |
GWASdb |
| chr8:141518974-141570542 |
chr8:141530825 |
rs7837045 |
LOC105375791 - MIR1302-7 |
Breast size |
regulatory_region_variant |
5e-06 |
GWAS_Catalog |
| chr8:141518974-141570542 |
chr8:141546705 |
rs1566080 |
LOC105375791 - MIR1302-7 |
Obesity-related traits |
intergenic_variant |
6e-06 |
GWAS_Catalog |